Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.

Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma. Curr Oncol Rep. 2019 03 27; 21(5):38.

View in: PubMed